Dr Hsiao is on the Board of Directors for the Hidradenitis Suppurativa Foundation; has served as a consultant for Boehringer Ingelheim, Novartis, and UCB; and has served as a consultant and speaker for AbbVie. Dr Aleshin has received research funding from UCB and has been a consultant for AbbVie. Dr Mayo has served as an investigator or consultant for Arcutis, Acelyrin, BMS, ChemoCentryx, Eli Lilly, Galderma, Janssen, Leo Pharma, Novartis, Pfizer, and Procter and Gamble. Dr Sayed is a speaker for Abbvie and Novartis; a consultant for Abbvie, Novartis, Incyte, UCB, and Alumis; and an investigator for Abbvie, Novartis, Incyte, Chemocentryx, UCB, and InflaRx. Dr Shi is on the board of directors for the Hidradenitis Suppurativa Foundation; is a stock shareholder of Learn Health;and has served as an advisory board member, investigator, speaker, and/or received research funding from Sanofi Genzyme, Regeneron, AbbVie, Eli Lilly, Alumis, Novartis, SUN Pharma, LEO Pharma, Pfizer, Incyte, Boehringer-Ingelheim, Aristea Therapeutics, Menlo Therapeutics, Dermira, Burt’s Bees, Galderma, Kiniksa, UCB, WebMD, TARGET-Pharmasolutions, Altus Lab, MYOR, Polyfin, GpSkin, and Skin Actives Scientific. Dr Okoye is on the Board of Directors for the Hidradenitis Suppurativa Foundation; has served as a consultant for Unilever and Janssen; received fellowship funding from Pfizer and Janssen; and served on Advisory Boards for Abbvie, Janssen, Lilly, Novartis, and UCB. There was no financial transaction for the preparation of this manuscript. Drs Shih, Lee, Bennett, and Villa have no conflicts of interest to declare.